We are live on ! Find out more
OKYO

OKYO Pharma
OKYO

7 hedge funds and large institutions have $176K invested in OKYO Pharma in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,187% more capital invested

Capital invested by funds: $13.7K → $176K (+$162K)

600% more funds holding

Funds holding: 1 → 7 (+6)

0.29% more ownership

Funds ownership: 0.05% → 0.34% (+0.29%)

Holders
7
Holders Change
+6
Holders Change %
+600%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
+$42K
2
Renaissance Technologies
Renaissance Technologies
New York
+$27.5K
3
Citadel Advisors
Citadel Advisors
Florida
+$26.8K
4
Morgan Stanley
Morgan Stanley
New York
+$23.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$20.3K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
1
Barclays
United Kingdom
$46.3K +$42K +25,000 New
Renaissance Technologies
2
Renaissance Technologies
New York
$30K +$27.5K +16,347 New
Citadel Advisors
3
Citadel Advisors
Florida
$29.5K +$26.8K +15,943 New
Morgan Stanley
4
Morgan Stanley
New York
$25.6K +$23.3K +13,846 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$22.4K +$20.3K +12,090 New
HSBC Holdings
6
HSBC Holdings
United Kingdom
$22.1K – – –
UBS Group
7
UBS Group
Switzerland
$176 +$160 +95 New

OKYO Hedge Fund Activity: Q3 2023 in Review

7 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in OKYO Pharma (OKYO) for Q3 2023, worth a combined $176K — up 1,187% from $13.7K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new OKYO positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Barclays, opening a new position worth an estimated $42K.

  • 7 institutional investors held OKYO Pharma (OKYO) as of Q3 2023, up from 1 in Q2 2023.
  • Funds reported $176K of OKYO Pharma stock for Q3 2023, up 1,187% quarter-over-quarter.
  • 6 funds opened new OKYO Pharma positions in Q3 2023 and 0 closed out, a net change of +6 holders.
  • The largest OKYO Pharma buyer in Q3 2023 was Barclays, an estimated $42K added.

Based on aggregated 13F filings for Q3 2023.